Literature DB >> 22740195

Locally recurrent colorectal cancer: results of surgical therapy.

M Kruschewski1, M Ciurea, S Lipka, S Daum, L Moser, B Meyer, J Gröne, J Budczies, H J Buhr.   

Abstract

PURPOSE: Up to 20 % of colorectal cancer patients develop recurrent disease despite standardized surgical techniques and multimodal treatment strategies. Radical resection is the central component of curative therapy in these cases. The aim of this study was to evaluate treatment results in patients with locoregionally recurrent colorectal cancer.
METHODS: From January 1995 to December 2007, surgery was performed for recurrent colorectal cancer in 82 patients who had undergone curative (R0) resection of their primary tumor. Assessment included patient, tumor and treatment characteristics, postoperative complications, and time without re-recurrence; recurrence-free and overall survival rates were calculated according to the Kaplan-Meier method.
RESULTS: Resection was performed in 60 of the 82 patients (73 %), repeat R0 resection in 52 % (31/60). Patients had a postoperative morbidity of 39 % (31/82), a relaparotomy rate of 13 % (11/82), and a lethality of 7 % (6/82). Forty-eight percent of all surgically-treated patients received a permanent stoma. Re-recurrence was seen in 52 % (16/31). R0 resection was associated with a 5-year survival rate of 35 % (11/31).
CONCLUSIONS: Extensive reinterventions often enable repeat R0 resection. Despite relevant morbidity, the lethality appears to be acceptable. Decisive for the prognosis is re-recurrence.

Entities:  

Mesh:

Year:  2012        PMID: 22740195     DOI: 10.1007/s00423-012-0975-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  39 in total

1.  Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy.

Authors:  Margo Shoup; Jose G Guillem; Kaled M Alektiar; Kathy Liau; Philip B Paty; Alfred M Cohen; W Douglas Wong; Bruce D Minsky
Journal:  Dis Colon Rectum       Date:  2002-05       Impact factor: 4.585

2.  Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?

Authors:  Nuh N Rahbari; Alexis B Ulrich; Thomas Bruckner; Marc Münter; Axel Nickles; Pietro Contin; Thorsten Löffler; Christoph Reissfelder; Moritz Koch; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

Review 3.  Prognostic factors after surgery for locally recurrent rectal cancer: an overview.

Authors:  M Caricato; D Borzomati; F Ausania; S Valeri; A Rosignoli; R Coppola
Journal:  Eur J Surg Oncol       Date:  2005-12-27       Impact factor: 4.424

4.  Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients.

Authors:  Thomas Lehnert; Mascha Methner; Andreas Pollok; Anja Schaible; Ulf Hinz; Christian Herfarth
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

5.  Abdominosacral resection of recurrent rectal cancer in the sacrum.

Authors:  J Zacherl; R Schiessel; R Windhager; F Herbst; J Karner-Hanusch; R Kotz; R Jakesz; B Teleky
Journal:  Dis Colon Rectum       Date:  1999-08       Impact factor: 4.585

6.  Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis.

Authors:  Yoshihiro Moriya; Takayuki Akasu; Shin Fujita; Seiichirou Yamamoto
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

7.  Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer.

Authors:  G H Mannaerts; H J Rutten; H Martijn; P E Hanssens; T Wiggers
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

8.  A population-based study on the management and outcome in patients with locally recurrent rectal cancer.

Authors:  G Palmer; A Martling; B Cedermark; T Holm
Journal:  Ann Surg Oncol       Date:  2006-12-02       Impact factor: 5.344

Review 9.  Neoadjuvant treatment for locally advanced rectal carcinoma.

Authors:  Lara Maria Pasetto; Salvatore Pucciarelli; Marco Agostini; Elena Rossi; Silvio Monfardini
Journal:  Crit Rev Oncol Hematol       Date:  2004-10       Impact factor: 6.312

10.  Total pelvic exenteration for primary and recurrent malignancies.

Authors:  F T J Ferenschild; M Vermaas; C Verhoef; A C Ansink; W J Kirkels; A M M Eggermont; J H W de Wilt
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

View more
  2 in total

Review 1.  Clinical review: surgical management of locally advanced and recurrent colorectal cancer.

Authors:  D Courtney; F McDermott; A Heeney; D C Winter
Journal:  Langenbecks Arch Surg       Date:  2013-11-19       Impact factor: 3.445

2.  CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis.

Authors:  Yang Zhao; Jing Peng; Enlong Zhang; Ning Jiang; Jiang Li; Qi Zhang; Xuening Zhang; Yuanjie Niu
Journal:  Oncotarget       Date:  2016-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.